169 related articles for article (PubMed ID: 32464192)
1. Neuroprotection: A versatile approach to combat glaucoma.
Naik S; Pandey A; Lewis SA; Rao BSS; Mutalik S
Eur J Pharmacol; 2020 Aug; 881():173208. PubMed ID: 32464192
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection: a new treatment modality for glaucoma?
Schwartz M; Yoles E
Curr Opin Ophthalmol; 2000 Apr; 11(2):107-11. PubMed ID: 10848215
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection: is it already applicable to glaucoma therapy?
Ritch R
Curr Opin Ophthalmol; 2000 Apr; 11(2):78-84. PubMed ID: 10848224
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection of the optic nerve in glaucoma.
Caprioli J
Acta Ophthalmol Scand; 1997 Aug; 75(4):364-7. PubMed ID: 9374241
[No Abstract] [Full Text] [Related]
5. Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis.
Guo X; Namekata K; Kimura A; Noro T; Azuchi Y; Semba K; Harada C; Yoshida H; Mitamura Y; Harada T
Neurosci Lett; 2015 Apr; 592():27-31. PubMed ID: 25736951
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cell-based approaches for neuroprotection in glaucoma.
Lebrun-Julien F; Di Polo A
Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
[TBL] [Abstract][Full Text] [Related]
7. Targeting neuronal gap junctions in mouse retina offers neuroprotection in glaucoma.
Akopian A; Kumar S; Ramakrishnan H; Roy K; Viswanathan S; Bloomfield SA
J Clin Invest; 2017 Jun; 127(7):2647-2661. PubMed ID: 28604388
[TBL] [Abstract][Full Text] [Related]
8. Neurodegeneration, Neuroprotection and Regeneration in the Zebrafish Retina.
Stella SL; Geathers JS; Weber SR; Grillo MA; Barber AJ; Sundstrom JM; Grillo SL
Cells; 2021 Mar; 10(3):. PubMed ID: 33809186
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
Almasieh M; Levin LA
Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection and Retinal Diseases.
Paulus YM; Campbell JP
Dev Ophthalmol; 2016; 55():322-9. PubMed ID: 26501142
[TBL] [Abstract][Full Text] [Related]
12. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199
[TBL] [Abstract][Full Text] [Related]
13. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
[TBL] [Abstract][Full Text] [Related]
14. Protecting the retinal neurons from glaucoma: lowering ocular pressure is not enough.
Pascale A; Drago F; Govoni S
Pharmacol Res; 2012 Jul; 66(1):19-32. PubMed ID: 22433276
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection in glaucoma.
Kaushik S; Pandav SS; Ram J
J Postgrad Med; 2003; 49(1):90-5. PubMed ID: 12865582
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective Strategies in Glaucoma.
Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
[TBL] [Abstract][Full Text] [Related]
17. Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma.
Yanagisawa M; Aida T; Takeda T; Namekata K; Harada T; Shinagawa R; Tanaka K
Cell Death Dis; 2015 Mar; 6(3):e1693. PubMed ID: 25789968
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications.
Fu L; Kwok SS; Chan YK; Ming Lai JS; Pan W; Nie L; Shih KC
Biomed Res Int; 2019; 2019():8397521. PubMed ID: 31828134
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection as a Therapeutic Target for Diabetic Retinopathy.
Hernández C; Dal Monte M; Simó R; Casini G
J Diabetes Res; 2016; 2016():9508541. PubMed ID: 27123463
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics and Signaling Pathways in Glaucoma.
Gauthier AC; Liu J
Biomed Res Int; 2017; 2017():5712341. PubMed ID: 28210622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
